Cargando…
ALK基因状态与晚期肺腺癌患者一线培美曲塞化疗疗效的关系
BACKGROUND AND OBJECTIVE: Anaplastic lymphoma kinase (ALK) is one of the major driver genes of non-small cell lung cancer (NSCLC). Several studies have shown that the efficacy of pemetrexed in ALK-positive lung cancer is controversial. The aim of this study is to explore the efficacy of pemetrexed-b...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973278/ https://www.ncbi.nlm.nih.gov/pubmed/29167001 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.11.02 |